Skip to content

Drug interactions

Granisetron + Ipratropium-salbutamol

Severity: Minor

Granisetron and Ipratropium-salbutamol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Granisetron can prolong the QT interval slightly, mainly at higher doses or with other risk factors. Salbutamol can cause tachycardia and hypokalemia, which may add to the arrhythmic risk. Clinical significance is usually low at standard doses.

What this interaction means in plain words

Granisetron and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Granisetron belongs to Gastrointestinal Tract; Ipratropium-salbutamol belongs to Respiratory.

Evidence level: Low

Why it happens

Possible additive QT prolongation, with beta-agonist-induced hypokalemia contributing.

What to do

No routine adjustment is needed; check potassium and consider an ECG if the patient has other QT risk factors or is using high-dose salbutamol.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Granisetron and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Granisetron with Ipratropium-salbutamol?

MediHelp rates the interaction as minor. Granisetron and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Granisetron can prolong the QT interval slightly, mainly at higher doses or with other risk factors. Salbutamol can cause tachycardia and hypokalemia, which may add to the arrhythmic risk. Clinical significance is usually low at standard doses.

How serious is the interaction between Granisetron and Ipratropium-salbutamol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; check potassium and consider an ECG if the patient has other QT risk factors or is using high-dose salbutamol.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in